The HLA DRB1*1501-DQB1*0602-DPB1*0501 haplotype is a risk factor for toluene diisocyanate-induced occupational asthma

International Archives of Allergy and Immunology

Volumn 150, Issue 2, 2009, Pages 156-163

  Choi, Jeong Hee ^a   Lee, Kyung Wha ^b   Kim, Cheol Woo ^c   Park, Choon Sik ^d   Lee, Hyun Young ^e   Hur, Gyu Young ^f   Kim, Seung Hyun ^e   Hong, Chein Soo ^g   Jang, An Soo ^d   Park, Hae Sim ^h  

^a Department of Internal Medicine ^*

^b Hallym University   (South Korea)

^c Inha University   (South Korea)

^d Soonchunhyang University   (South Korea)

^e Ajou University   (South Korea)

^f Korea University   (South Korea)

^g Yonsei University   (South Korea)

^h Ajou University School of Medicine   (South Korea)

Author keywords

Asthma; Human leukocyte antigen class; Immunoglobulin E; Toluene diisocyanate

Indexed keywords

ALBUMIN CONJUGATE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN E ANTIBODY; TOLUENE DIISOCYANATE; HLA DP ANTIGEN; HLA DPB1*0501; HLA DQ ANTIGEN; HLA DQB1 PROTEIN, HUMAN; HLA DRB1*1501, HUMAN; HLA-DPB1*0501; HLA-DQB1 PROTEIN, HUMAN; HLA-DRB1*1501, HUMAN; IMMUNOGLOBULIN E; MEMBRANE PROTEIN;

ADULT; ALLELE; ARTICLE; ASIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC MARKER; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL ASTHMA; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SENSITIZATION; STATISTICAL SIGNIFICANCE; ASTHMA; BLOOD; CHEMICALLY INDUCED DISORDER; FORCED EXPIRATORY VOLUME; GENETICS; IMMUNOLOGY; KOREA; MIDDLE AGED; OCCUPATIONAL DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ASTHMA; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; HAPLOTYPES; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN E; KOREA; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OCCUPATIONAL DISEASES; RISK FACTORS; TOLUENE 2,4-DIISOCYANATE;

EID: 65549113060     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218118     Document Type: Article

References (29)

1. Wisnewski AV, Redlich CA, Mapp CE, Bernstein DI: Polyisocyanates and their prepolymers; in Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI (eds): Asthma in the Workplace, ed 3. New York, Tayor & Francis Group, 2006, pp 481-504.
2. Mapp CE: Agents, old and new, causing occupational asthma. Occup Environ Med 2001; 58: 354-360.
3. Kim YY, Cho SH, Yoon HJ, Min KU, Back DM, Jung KC: Isocyanate-induced occupational asthma in Korea. Korean J Med (Korean) 1994; 47: 439-453.
4. Park HS, Park JN, Kim JW, Kim SK: Clinical and immunological evaluation of isocyanate- exposed workers. J Korean Med Sci 1992; 7: 122-127.
5. Baur X: Occupational asthma due to isocyanates. Lung 1996; 174: 23-30. (Pubitemid 26006127)
6. Wisnewski AV, Redlich CA: Recent developments in diisocyanate asthma. Curr Opin Allergy Clin Immunol 2001; 1: 169-175.
7. Park HS, Cho SH, Hong CS, Kim YY: Isocyanate-induced occupational asthma in fareast Asia: pathogenesis to prognosis. Clin Exp Allergy 2002; 32: 198-204.
8. Liu Q, Wisnewski AV: Recent developments in diisocyanate asthma. Ann Allergy Asthma Immunol 2003; 90(suppl 2):35-41.
9. Wisnewski AV: Developments in laboratory diagnostics for isocyanate asthma. Curr Opin Allergy Clin Immunol 2007; 7: 138-145.
10. Cartier A, Grammer L, Malo JL, Lagier F, Ghezzo H, Harris K, Patterson R: Specific serum antibodies against isocyanates: association with occupational asthma. J Allergy Clin Immunol 1989; 84: 507-514.
11. Park HS, Lee SK, Kim HY, Nahm DH, Kim SS: Specific immunoglobulin E and immunoglobulin G antibodies to toluene diisocyanate- human serum albumin conjugate: useful markers for predicting long-term prognosis in toluene diisocyanate-induced asthma. Clin Exp Allergy 2002; 32: 551-555.
12. Bentley AM, Maestrelli P, Saetta M, Fabbri LM, Robinson DS, Bradley BL, Jeffery PK, Durham SR, Kay AB: Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol 1992; 89: 821-829.
13. Maestrelli P, Occari P, Turato G, Papiris SA, Di Stefano A, Mapp CE, Milani GF, Fabbri LM, Saetta M: Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI). Clin Exp Allergy 1997; 27: 1292-1298.
14. Wisnewski AV, Srivastava R, Herick C, Xu L, Lemus R, Cain H, Magoski NM, Karol MH, Bottomly K, Redlich CA: Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo. Am J Respir Crit Care Med 2000; 162: 2330-2336.
15. Choi JH, Nahm DH, Kim SH, Kim YS, Suh CH, Park HS, Ahn SW: Increased levels of IgG to cytokeratin 19 in sera of patients with toluene diisocyanate-induced asthma. Ann Allergy Asthma Immunol 2004; 93: 293-298.
16. Acton RT: The major histocompatibility complex; in Rich RR, Fleisher TA, Shearer WT, Kotzin BL, Schroeder HWJ (eds): Clinical Immunology, ed 2. London, Mosby, 2001, pp 6.1-6.13.
17. Bignon JS, Aron Y, Ju LY, Kopferschmitt MC, Garnier R, Mapp C, Fabbri LM, Pauli G, Lockhart A, Charron D, Swierczewski E: HLA class II alleles in isocyanate-induced asthma. Am J Respir Crit Care Med 1994; 149: 71-75.
18. Balboni A, Baricordi OR, Fabbri LM, Gandini E, Ciaccia A, Mapp CE: Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57. Eur Respir J 1996; 9: 207-210.
19. Mapp CE, Beghe B, Balboni A, Zamorani G, Padoan M, Jovine L, Baricordi OR, Fabbri LM: Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma. Clin Exp Allergy 2000; 30: 651-656.
20. Rihs HP, Barbalho-Krolls T, Huber H, Baur X: No evidence for the influence of HLA class II in alleles in isocyanate-induced asthma. Am J Ind Med 1997; 32: 522-527.
21. Kim SH, Oh HB, Lee KW, Shin ES, Kim CW, Hong CS, Nahm DH, Park HS: HLA DRB*15-DPB1*05 haplotype: a susceptible gene marker for isocyanate-induced occupational asthma? Allergy 2006; 61: 891-894.
22. Park HS, Kim HY, Nahm DH, Son JW, Kim YY: Specific IgG, but not specific IgE, antibodies to toluene diisocyanate-human serum albumin conjugate are associated with toluene diisocyanate bronchoprovocation test results. J Allergy Clin Immunol 1999; 104: 847-851.
23. Ye YM, Kim CW, Kim HR, Kim HM, Suh CH, Nahm DH, Park HS, Redlich CA, Wisnewski AV: Biophysical determinants of toluene diisocyanate antigenecity associated with exposure and asthma. J Allergy Clin Immunol 2006; 118: 885-891.
24. Wisnewski AV, Stowe MH, Cartier A, Liu Q, Liu J, Chen L, Redlich CA: Isocyanate vaporinduced antigenicity of human albumin. J Allergy Clin Immunol 2004; 113: 1178-1184.
25. Blasczyk R: Sequence-based typing for HLADRB1 and DRB3/4/5 separating alleles; in Tilanus MGJ, Hansen JA, Hurley CK (eds): IHWG Technical Manual. Seattle, International Histocompatibility Working Group, 2000, TM10C 1-10.
26. Schneider S, Rosseli D, Excoffier L: Arlequin 2000: a software for population genetics data analysis. Genetics and Biometry Laboratory, University of Geneva, 2000.
27. Bernstein JA, Munson J, Lummus ZL, Balakrishnan K, Leikauf G: T-cell receptor V beta gene segment expression in diisocyanate-induced occupational asthma. J Allergy Clin Immunol 1997; 99: 245-250.
28. Maestrelli P, Del Prete GF, De Carli M, D'Elios MM, Saetta M, Di Stefano A, Mapp CE, Romagnani S, Fabbri LM: CD8 T-cell clones producing interleukin-5 and interferon- gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate. Scand J Work Environ Health 1994; 20: 376-381.
29. Beghe B, Padoan M, Moss CT, Barton SJ, Holloway JW, Holgate ST, Howell WM, Mapp CE: Lack of association of HLA class I genes and TNF alpha-308 polymorphism in toluene diisocyanate-induced asthma. Allergy 2004; 59: 61-64.